Concepedia

Bikash Debnath

BD

Statistics

Publications

33

Citations

1.5K

H-Index

22

Active since

2002

Affiliations

Jadavpur University(Current)

University of Southern California

University of Michigan

Michigan Medicine

Shanghai Institute of Materia Medica

Bikash Debnath is an author at Jadavpur University specializing in drug discovery, pharmacology, and medicinal chemistry.

ORCID

Publications per year

2002–2025

33

Publications

33

Discovery of an orally active small-molecule irreversible inhibitor of protein disulfide isomerase for ovarian cancer treatment

Shili Xu, Alexey N. Butkevich, Roppei Yamada et al. · Proceedings of the National Academy of Sciences · 2012 · 242 citations · Full text

, , +14

Sources and toxicological effects of lead on human health

Kuntal Manna, Bikash Debnath, WaikhomSomraj Singh · Indian Journal of Medical Specialities · 2019 · 175 citations · Full text

, , +14

The Hydroxyquinoline Analogue YUM70 Inhibits GRP78 to Induce ER Stress–Mediated Apoptosis in Pancreatic Cancer

Soma Samanta, Suhui Yang, Bikash Debnath et al. · Cancer Research · 2021 · 119 citations · Full text

, , +17

Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor

Kavya Ramkumar, Soma Samanta, Anahita Kyani et al. · Nature Communications · 2016 · 74 citations · Full text

, , +13

Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy

Brandt C. Huddle, Edward Grimley, Cameron D. Buchman et al. · Journal of Medicinal Chemistry · 2018 · 68 citations · Full text

, , +10

1–5 of 33